Fiche publication
Date publication
octobre 2014
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier
Tous les auteurs :
Khadige M, Peiffert D, Supiot S
Lien Pubmed
Résumé
Prostate cancer radiotherapy has evolved from the old 2D technique to conformal, and then to intensity-modulated radiation therapy (IMRT) and stereotactic radiotherapy. At the same time, image-guidance (IGRT) is routinely used. New techniques such as protontherapy or carbontherapy are being developed with the objective of increased efficacy, decreased treatment duration, toxicity or cost. This review summarizes the evidence-based medicine of new technologies in the treatment of prostate cancer.
Mots clés
Adenocarcinoma, radiotherapy, Brachytherapy, adverse effects, Clinical Trials as Topic, Dose Fractionation, Epidemiologic Studies, Evidence-Based Medicine, Heavy Ion Radiotherapy, adverse effects, Humans, Male, Organs at Risk, Prostatic Neoplasms, radiotherapy, Proton Therapy, adverse effects, Quality of Life, Radiation Injuries, etiology, Radiosurgery, adverse effects, Radiotherapy, Image-Guided, adverse effects, Therapies, Investigational
Référence
Cancer Radiother. 2014 Oct;18(5-6):501-8
